Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in Eur J Cancer

Retrieve available abstracts of 15 articles:
HTML format
Text format



Single Articles


    July 2017
  1. PARK SR, Kim MJ, Nam BH, Kim CG, et al
    A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer.
    Eur J Cancer. 2017;83:32-42.
    PubMed     Text format     Abstract available


    April 2017
  2. DESIDERIO J, Chao J, Melstrom L, Warner S, et al
    The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
    Eur J Cancer. 2017;79:1-14.
    PubMed     Text format     Abstract available


    February 2017
  3. IENI A, Angelico G, Zeppa P, Tuccari G, et al
    Letter to the Editor regarding the paper by Park et al., Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER
    Eur J Cancer. 2017;75:190-191.
    PubMed     Text format    


    December 2016
  4. OH HJ, Lim CH, Yoon BH, Yoon SB, et al
    Fracture after gastrectomy for gastric cancer: A long-term follow-up observational study.
    Eur J Cancer. 2016;72:28-36.
    PubMed     Text format     Abstract available


    August 2016
  5. YOSHINO S, Nishikawa K, Morita S, Takahashi T, et al
    Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
    Eur J Cancer. 2016;65:164-171.
    PubMed     Text format     Abstract available


    July 2016
  6. TSAI MM, Wang CS, Tsai CY, Huang CG, et al
    Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
    Eur J Cancer. 2016;64:137-148.
    PubMed     Text format     Abstract available


    May 2016
  7. YOSHIKAWA T, Morita S, Tanabe K, Nishikawa K, et al
    Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric
    Eur J Cancer. 2016;62:103-111.
    PubMed     Text format     Abstract available


  8. BANDO H, Doi T, Muro K, Yasui H, et al
    A multicenter phase II study of TAS-102 monotherapy in patients with pre-treated advanced gastric cancer (EPOC1201).
    Eur J Cancer. 2016;62:46-53.
    PubMed     Text format     Abstract available


    April 2016
  9. MONTALVO-JAVE EE, Olguin-Martinez M, Hernandez-Espinosa DR, Sanchez-Sevilla L, et al
    Role of NADPH oxidases in inducing a selective increase of oxidant stress and cyclin D1 and checkpoint 1 over-expression during progression to human gastric adenocarcinoma.
    Eur J Cancer. 2016;57:50-7.
    PubMed     Text format     Abstract available


    December 2015
  10. PARK SR, Park YS, Ryu MH, Ryoo BY, et al
    Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1).
    Eur J Cancer. 2015;53:42-50.
    PubMed     Text format     Abstract available


  11. LEE HH, Park JM, Song KY, Choi MG, et al
    Survival impact of postoperative body mass index in gastric cancer patients undergoing gastrectomy.
    Eur J Cancer. 2015;52:129-137.
    PubMed     Text format     Abstract available


    November 2015
  12. FANG X, Wei J, He X, An P, et al
    Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studies.
    Eur J Cancer. 2015 Nov 14. pii: S0959-8049(15)00856.
    PubMed     Text format     Abstract available


    September 2015
  13. SYLVIE L, Silvia S, Salah-Eddin AB, Markus F, et al
    Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced oesophagogastric cancer.
    Eur J Cancer. 2015;51:1918-26.
    PubMed     Text format     Abstract available


    June 2015
  14. ARNOLD M, Karim-Kos HE, Coebergh JW, Byrnes G, et al
    Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory.
    Eur J Cancer. 2015;51:1164-87.
    PubMed     Text format     Abstract available


    March 2015
  15. LORENZEN S, Riera Knorrenschild J, Haag GM, Pohl M, et al
    Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.
    Eur J Cancer. 2015;51:569-76.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: